Ayako Hattori

mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment

A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria

De novo variants in SETD1B cause intellectual disability, autism spectrum disorder, and epilepsy with myoclonic absences

Biallelic mutations in SZT2 cause a discernible clinical entity with epilepsy, developmental delay, macrocephaly and a dysmorphic corpus callosum